eClinical Technology and Industy News

MEI Pharma Announces Changes to Board of Directors

Excerpt from the Press Release:

SAN DIEGO–(BUSINESS WIRE)–MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Christine A. White, M.D., has decided to retire and thus does not intend to stand for reelection at the Company’s fiscal year 2023 annual meeting of stockholders after a seven-year tenure as chair of the board and 12 years total serving as a director. Charles V. Baltic III, J.D., who has served on the board since 2011, has been elected to replace Dr. White as chair of the board. Dr. White’s retirement and Mr. Baltic’s assumption of the chair are effective as of the Company’s fiscal year 2023 annual meeting of stockholders.

“On behalf of the board and management, I would like to thank Christine for her unwavering dedication and strategic guidance during her 12-year tenure on the board of directors,” said Daniel P. Gold, Ph.D., president and chief executive officer of MEI Pharma. “She is a remarkable person and an oncology biopharmaceutical thought leader who has provided invaluable leadership, grounded insight and clear direction, which has significantly supported MEI’s growth and the advancement of its oncology drug candidates. We sincerely wish her all the best in her retirement.”

Dr. Gold continued: “Although we will miss Christine, we are very fortunate to have Charles as our chair elect. We look forward to working with Charles in his new capacity as board chair to leverage his history and familiarity with MEI. His extensive industry and professional experience will be invaluable in advancing our mission to improve outcomes for patients with cancer through our efforts to develop and commercialize novel, best-in-class therapies.”

Click the button below to read the entire Press Release:

Continue Reading The Press Release

Discover What Sets TrialStat Apart From Ordinary EDC Platforms

Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives